Wells Fargo Cuts Globe Life (GL) Price Target to $180
Key Points
- Wells Fargo reduced its price target on Globe Life from $191 to $180, reflecting ongoing analysis of the company's performance and market conditions.
- Wells Fargo's $180 price target implies 14% upside from Globe Life Inc.'s ($GL) current $157.90 share price.
- The stock is currently trading around $157.9, approximately 15.9% below the mean analyst price target of $187.82.
- Globe Life has a market cap of about $11.9 billion and a P/E ratio of 10.36, indicating its value relative to earnings.
Get Globe Life text alerts
We text you when insiders, Congress, analysts or big funds move on $GL.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Globe Life Inc. alert may contain errors. Disclosures
On October 26, 2026, Wells Fargo lowered its price target on Globe Life Inc. (GL) to $180 from $191 while keeping its Overweight rating. This adjustment comes as analysts reassess the company's performance based on recent market conditions and earnings results.
GL
Globe Life Inc.
Wells Fargo vs. the S&P 500
Hypothetical returns from Wells Fargo's disclosed trades, not real profit or advice. How we model this.
Wells Fargo's Call on Globe Life
Wells Fargo maintained an Overweight rating on Globe Life but adjusted its price target down from $191 to $180. The firm’s decision reflects its ongoing evaluation of the company’s potential and market challenges. This downgrade follows other recent analyst actions, including Piper Sandler's downgrade to Neutral with a target of $165 and Evercore ISI Group maintaining a target of $174.
Other Institutional Activity in Globe Life
AQR Capital Management, LLC grew its holdings in Globe Life by 318,052 shares, bringing its total to about 1.5 million shares worth approximately $239.4 million. Meanwhile, Nuveen, LLC reduced its stake slightly by 2,248 shares, resulting in about 1.5 million shares valued at around $236.3 million.
Globe Life Inc. Stock Down 6.2%
As of October 26, 2026, Globe Life shares closed at $157.9, which is about equal to that day's closing price. The stock is trading below its 50-day moving average by 7.2% and is 17.6% off its 52-week high of $191.55, indicating potential challenges in gaining momentum.
$GL price target
Globe Life Inc. daily closes and this analyst's $180 target. Not advice.
Recent Earnings
Globe Life reported trailing twelve-month revenue of approximately $6.27 billion, with an EPS of $14.94. The company has shown a revenue growth of 5.5% year-over-year and a net margin of 18.9%. Its next earnings report is scheduled for February 3, 2027.
Dividend
Globe Life pays an annual dividend of $1.32 per share, which translates to a dividend yield of approximately 0.85%. The company has a dividend payout ratio of 8.0%, indicating a sustainable approach to returning value to shareholders.
Insider Buying and Selling at Globe Life Inc.
Several insiders sold shares recently. Michael Clay Majors, an officer, sold 37,000 shares valued at about $6.6 million on July 29, 2026. Chief Financial Officer Thomas Peter Kalmbach sold 21,000 shares worth about $3.8 million on July 30, 2026. CEO James Matthew Darden sold 50,000 shares for approximately $9.1 million on July 31, 2026. These transactions were not under a planned trading strategy.
Analysts Set New Price Targets
On October 26, 2026, Wells Fargo maintained its Overweight rating while lowering its price target to $180 from $191. This comes after several other analysts adjusted their targets, including Piper Sandler, which downgraded to a Neutral rating with a target of $165, and TD Cowen, which maintained a Buy rating with a target of $215.
About Globe Life
Globe Life Inc. provides life and supplemental health insurance products primarily to lower middle- and middle-income families in the U.S. It operates in three segments: Life Insurance, Supplemental Health Insurance, and Investments. The company's recent adjustments in analyst targets reflect its ongoing market performance and future growth potential.
Bottom Line
Investors should keep an eye on Globe Life's upcoming earnings report on February 3, 2027, and watch for further analyst updates regarding its price targets and market outlook.
Related Filing Alerts
Source: Wells Fargo's rating change on $GL (Oct 26, 2026). Written by software, not financial advice. How we make alerts